These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20446939)

  • 1. Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience.
    Breuer L; Schellinger PD; Huttner HB; Halwachs R; Engelhorn T; Doerfler A; Köhrmann M
    Int J Stroke; 2010 Apr; 5(2):68-73. PubMed ID: 20446939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.
    Schellinger PD; Thomalla G; Fiehler J; Köhrmann M; Molina CA; Neumann-Haefelin T; Ribo M; Singer OC; Zaro-Weber O; Sobesky J
    Stroke; 2007 Oct; 38(10):2640-5. PubMed ID: 17702961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the Primary Imaging Modality-Computed Tomography or Magnetic Resonance Imaging-Influence Stroke Physicians' Certainty on Whether or Not to Give Thrombolysis to Randomized Acute Stroke Patients?
    Hansen CK; Christensen A; Rodgers H; Havsteen I; Kruuse C; Christensen H
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):926-935. PubMed ID: 29198901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study.
    Kang DW; Sohn SI; Hong KS; Yu KH; Hwang YH; Han MK; Lee J; Park JM; Cho AH; Kim HJ; Kim DE; Cho YJ; Koo J; Yun SC; Kwon SU; Bae HJ; Kim JS
    Stroke; 2012 Dec; 43(12):3278-83. PubMed ID: 23093613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
    Ma H; Parsons MW; Christensen S; Campbell BC; Churilov L; Connelly A; Yan B; Bladin C; Phan T; Barber AP; Read S; Hankey GJ; Markus R; Wijeratne T; Grimley R; Mahant N; Kleinig T; Sturm J; Lee A; Blacker D; Gerraty R; Krause M; Desmond PM; McBride SJ; Carey L; Howells DW; Hsu CY; Davis SM; Donnan GA;
    Int J Stroke; 2012 Jan; 7(1):74-80. PubMed ID: 22188854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke Volume Predicts Nocturnal Hypoxemia in the Acute Ischemic Stroke after Intravenous Thrombolysis.
    Huhtakangas JK; Saaresranta T; Bode MK; Bloigu R; Huhtakangas J
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2481-2487. PubMed ID: 31277996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.
    Gerischer LM; Fiebach JB; Scheitz JF; Audebert HJ; Endres M; Nolte CH
    Cerebrovasc Dis; 2013; 35(3):250-6. PubMed ID: 23548768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.
    Koga M; Toyoda K; Kimura K; Yamamoto H; Sasaki M; Hamasaki T; Kitazono T; Aoki J; Seki K; Homma K; Sato S; Minematsu K;
    Int J Stroke; 2014 Dec; 9(8):1117-24. PubMed ID: 25088843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous magnetic resonance perfusion imaging acquisition during systemic thrombolysis in acute stroke.
    Griebe M; Kern R; Eisele P; Sick C; Wolf ME; Sauter-Servaes J; Gregori J; Günther M; Hennerici MG; Szabo K
    Cerebrovasc Dis; 2013; 35(6):554-9. PubMed ID: 23838705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke.
    Yoo SH; Kwon SU; Lee DH; Kim SJ; Kim JS; Kang DW
    J Neurol Sci; 2010 Jul; 294(1-2):119-23. PubMed ID: 20441993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
    Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial).
    Thomalla G; Boutitie F; Fiebach JB; Simonsen CZ; Nighoghossian N; Pedraza S; Lemmens R; Roy P; Muir KW; Ebinger M; Ford I; Cheng B; Galinovic I; Cho TH; Puig J; Thijs V; Endres M; Fiehler J; Gerloff C;
    Stroke; 2017 Mar; 48(3):770-773. PubMed ID: 28174327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous thrombolysis in posterior cerebral artery infarctions.
    Breuer L; Huttner HB; Jentsch K; Blinzler C; Winder K; Engelhorn T; Köhrmann M
    Cerebrovasc Dis; 2011; 31(5):448-54. PubMed ID: 21346350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.